The debate on gene patenting, while still unresolved, can be simplified.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Eisenberg, R.E. & Merges, R.P. Am. Intell. Prop. L. Assn. Q. J. 1, 3–51 (1995).
Eisenberg, R.E. Nat. Genet. 15, 125–130 (1997).
Directive 98/44/EC, Official Journal of the European Communities, Article 3.2 (30 July 1998).
Biogen Decision T 301/87, Official Journal of the European Patent Office 8, 335 (1990).
Genentech v. Wellcome Foundation, UK Court of Appeal, Judgement, 1989 Reports of Patent Cases 8, 147–203 and 9, 203–287 published by The Patent Office, London.
Amgen Inc. v. Chugai Pharmaceutical, 13 USPQ 2d 1737–1797 and 18 USPQ 2d 1017–1031 (1989, 1991).
Fiers v. Sugano, 25 USPQ 2d 1601–1607 (1993).
Regents of the University of California v. Eli Lilly & Co., 119 F.3d 1559, 1566 (1997).
Flores, M.A. Nat. Biotechnol. 17, 819–820 (1999).
Mays, T.D. Bio-Science Law Review 2, 56–66 (1999/2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crespi, R. Patents on genes: clarifying the issues. Nat Biotechnol 18, 683–684 (2000). https://doi.org/10.1038/76548
Issue Date:
DOI: https://doi.org/10.1038/76548